Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy

Infection. 1993 Jul-Aug;21(4):206-9. doi: 10.1007/BF01728888.

Abstract

Serum kinetics of trimethoprim and sulfamethoxazole were studied in 23 patients during oral and i.v. treatment of Pneumocystis carinii pneumonia. Daily doses of 15-22 mg/kg trimethoprim and 75-110 mg/kg sulfamethoxazole were given every 6 h. Despite administration of a loading dose of twice the regular dose, serum trough concentrations continuously rose from 12 h to 96 h by 63% for trimethoprim and 102% for sulfamethoxazole. After 4-6 days mean trough concentrations of trimethoprim and sulfamethoxazole were 7.7 +/- 3.0 and 198 +/- 74 mg/l, with individual values of < 4.6 and < 103 mg/l in two patients and > 11.4 and > 307 mg/l in two others. Patients treated orally or i.v. had similar serum levels. However, large interindividual variability was observed despite weight-specific dosing. Administration of a loading dose did not prevent accumulation of serum levels of trimethoprim and sulfamethoxazole over several days of treatment.

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Administration, Oral
  • Adult
  • Aged
  • Body Weight
  • Creatinine / blood
  • Drug Monitoring
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Pneumonia, Pneumocystis / drug therapy*
  • Prospective Studies
  • Sulfamethoxazole / administration & dosage
  • Sulfamethoxazole / analogs & derivatives
  • Sulfamethoxazole / blood
  • Sulfamethoxazole / metabolism
  • Sulfamethoxazole / pharmacokinetics*
  • Sulfamethoxazole / therapeutic use
  • Time Factors
  • Trimethoprim / administration & dosage
  • Trimethoprim / metabolism
  • Trimethoprim / pharmacokinetics*
  • Trimethoprim / therapeutic use

Substances

  • N(4)-acetylsulfamethoxazole
  • Trimethoprim
  • Creatinine
  • Sulfamethoxazole